Analyst Reco. Veradigm Inc.

Equities

MDRX

US01988P1084

Delayed OTC Markets Other stock markets 02:18:25 2024-04-26 pm EDT			5-day change	1st Jan Change
7.96 ^USD	+0.13%		+4.74%	-24.12%

Apr. 03	Veradigm and Vim Announce Strategic Collaboration to Improve Payer-Provider Collaboration	CI
Mar. 19	Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15	Mar. 19	MT
RBC Halves Price Target on Veradigm to $11 From $22, Keeps Outperform Rating	Jan. 19	MT
Barclays Starts Allscripts Healthcare Solutions With Equalweight Rating, $11 Price Target	Jan. 03	MT
Deutsche Bank Adjusts Veradigm Price Target to $15 From $18, Maintains Buy Rating	Dec. 11	MT
Argus Research Downgrades Allscripts Healthcare Solutions to Hold From Buy	23-07-06	MT
Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $18 From $21, Maintains Buy Rating	23-06-30	MT
Stephens Initiates Allscripts Healthcare Solutions at Equalweight With $13 Price Target	23-04-12	MT
Piper Sandler Downgrades Veradigm to Neutral From Overweight, Adjusts Price Target to $18.50 From $17	23-02-01	MT
JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintains Underweight Rating	22-11-18	MT
Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Price Target to $23 From $22	22-11-09	MT
Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Maintains Buy Rating	22-11-07	MT
Deutsche Bank Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $26, Maintains Buy Rating	22-10-06	MT
KeyBanc Initiates Coverage on Allscripts Healthcare Solutions With Sector Weight Rating	22-09-16	MT
Goldman Sachs Starts Allscripts Healthcare Solutions at Neutral With $21 Price Target	22-07-12	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $17 From $19, Maintains Neutral Rating	22-06-10	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $22 From $19, Maintains Neutral Rating	22-03-18	MT
Deutsche Bank Lifts Allscripts Healthcare Solutions to Buy From Hold, Price Target to $26 From $20	22-03-04	MT
SVB Leerink Adjusts Allscripts Healthcare Solutions' Price Target to $24 from $22, Keeps Outperform Rating	22-03-03	MT
SVB Leerink Upgrades Allscripts Healthcare Solutions to Outperform from Market Perform, Adjusts Price Target to $22 from $19	22-01-25	MT
Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $19 From $17, Maintains Neutral Rating	22-01-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Veradigm Inc.

Equities

MDRX

US01988P1084

Analyst Reco.

Filters